How AI Wearables Are Uncovering Hidden Hormone Disruptions

By VirentaNews Staff — May 18, 2026

In a quiet conference hall in Prague, a quiet revolution in reproductive medicine unfolded. Researchers gathered around a single slide showing jagged, pulsating hormone curves—data not from blood draws, but from tiny adhesive patches worn on the skin for days. These unassuming devices, no larger than a Band-Aid, had recorded the ebb and flow of reproductive hormones in real time, revealing something startling: even in individuals with normal lab results, the delicate choreography of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estradiol was often out of sync. For years, couples struggling to conceive despite appearing hormonally healthy have faced a medical dead end. Now, thanks to a fusion of wearable biosensing and artificial intelligence, scientists are uncovering a hidden layer of dysfunction—disruptions in the timing and coordination of hormone pulses that traditional diagnostics simply cannot capture.

Real-Time Hormone Monitoring Reveals Hidden Patterns

At the 28th European Congress of Endocrinology, a team from the University of Copenhagen presented findings from a pilot study involving 42 individuals—men and women—with unexplained infertility. Each participant wore a flexible, skin-adherent patch equipped with microfluidic sensors that sampled interstitial fluid every 10 minutes over 72 hours. This continuous stream of data was then analyzed by an AI algorithm trained to recognize normal and abnormal pulsatility patterns in reproductive hormones. Shockingly, 38 of the 42 participants—over 90%—exhibited irregular hormone pulses despite having blood test results within standard reference ranges. The AI detected erratic LH surge timing, blunted peaks, and disrupted feedback loops between the pituitary and gonads, all of which could impair ovulation or sperm production. According to researchers, this suggests that conventional endocrine testing, which relies on static snapshots, may miss dynamic dysfunctions critical to fertility.

From Blood Tests to Biosensors: A Diagnostic Evolution

For decades, endocrinology has relied on blood tests taken at single time points to assess hormone levels. While useful for detecting overt deficiencies or excesses—such as hypothyroidism or polycystic ovary syndrome (PCOS)—this approach fails to capture the dynamic nature of hormone secretion. Reproductive hormones, particularly gonadotropins like LH and FSH, are released in pulses from the pituitary gland, with precise timing essential for follicular development, ovulation, and spermatogenesis. Yet standard clinical protocols rarely account for this rhythmicity. The advent of wearable biosensors marks a paradigm shift, enabling continuous, non-invasive monitoring. Early prototypes emerged from diabetes management, where continuous glucose monitors transformed care. Now, similar principles are being applied to endocrinology. The current AI-driven patches build on research from MIT and Stanford, where machine learning models were trained on decades of hormone pulse data from the NIH’s Reproductive Medicine Network.

The Scientists Behind the Sensors

The Danish-led study was spearheaded by Dr. Lene Andersen, a reproductive endocrinologist at Rigshospitalet, and Dr. Mikkel Flyvholm, a biomedical engineer specializing in microfluidics at the Technical University of Denmark. Their collaboration began five years ago, driven by frustration with the limitations of current fertility diagnostics. “We kept seeing patients with perfect blood work but no pregnancies,” Andersen said in an interview. “We suspected something was off in the timing, but we had no way to measure it.” Flyvholm’s team developed the patch using nanoscale sensors capable of detecting picomolar concentrations of hormones in interstitial fluid. The AI component, built in partnership with a Copenhagen-based health tech firm, uses recurrent neural networks to identify pulse patterns and flag anomalies. Their goal is not just diagnosis, but personalized treatment—adjusting medication timing to align with a patient’s unique hormonal rhythm.

Implications for Patients and Clinicians

The ability to detect subclinical hormone disruptions could redefine infertility care. For patients, it offers answers where none existed, potentially sparing them years of fruitless treatments. For clinicians, it opens the door to precision endocrinology—tailoring interventions like gonadotropin therapy or pulsatile GnRH delivery to individual pulse profiles. Insurance providers may also take note: early detection could reduce long-term costs associated with repeated IVF cycles. However, challenges remain. The patches are not yet commercially available, and regulatory approval will require larger trials. There are also privacy concerns around continuous health data. Still, experts say the benefits outweigh the risks. As the World Health Organization notes, infertility affects up to 1 in 6 couples globally, making this innovation potentially transformative.

The Bigger Picture

This breakthrough is part of a broader shift toward dynamic physiology—moving beyond static biomarkers to understand how the body functions in real time. Just as wearable ECG monitors have revolutionized cardiology, continuous hormone tracking could reshape endocrinology. The implications extend beyond fertility to conditions like adrenal insufficiency, metabolic syndrome, and even mood disorders linked to hormonal fluctuations. By revealing the hidden rhythms of the endocrine system, AI-powered wearables may finally allow medicine to treat the whole, living system—not just its snapshots.

What comes next is a new era of reproductive diagnostics, where a small patch on the skin might hold the key to conception. Clinical trials are expanding to include diverse populations, and researchers are exploring integration with fertility apps and electronic health records. If successful, these devices could become standard in fertility clinics within the next five years. For the millions navigating the anguish of unexplained infertility, that future cannot come soon enough.

Source: MedicalXpress